Development of anti-angiogenic erlotinib liposomal formulation for pulmonary hypertension: a QbD approach

Overview of attention for article published in Drug Delivery and Translational Research, April 2019

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,813 followers.

Development of anti-angiogenic erlotinib liposomal formulation for pulmonary hypertension: a QbD approach. https://t.co/HyJzwwc9Jv

Publication from our group targeting a condition on rise.. pulmonary hypertension. https://t.co/TmYSyuXznn